Literature DB >> 34469618

The effects of pulmonary hypertension on skeletal muscle oxygen pressures in contracting rat spinotrapezius muscle.

Kiana M Schulze1, Ramona E Weber1, Trenton D Colburn1, Andrew G Horn1, Carl J Ade1, Wei-Wen Hsu2, David C Poole1,3, Timothy I Musch1,3.   

Abstract

NEW
FINDINGS: What is the central question of this study? Does impairment in the dynamics of O2 transport in skeletal muscle during a series of contractions constitute a potential mechanism underlying reduced exercise capacity in pulmonary hypertension? What is the main finding and its importance? Pulmonary hypertension compromises the dynamic matching of skeletal muscle O2 delivery-to-utilization following contraction onset in the rat spinotrapezius muscle. These results implicate a role for vascular dysfunction in the slow V̇O2 kinetics and exercise intolerance present in pulmonary hypertension. ABSTRACT: Pulmonary hypertension (PH) is characterized by pulmonary vascular dysfunction and exercise intolerance due, in part, to compromised pulmonary and cardiac function. We tested the hypothesis that there are peripheral (i.e., skeletal muscle) aberrations in O2 delivery ( Q̇O2 )-to-O2 utilization ( V̇O2 ) matching and vascular control that might help to explain poor exercise tolerance in PH. Furthermore, we investigated the peripheral effects of nitric oxide (NO) in attenuating these decrements. Male Sprague-Dawley rats (n = 21) were administered monocrotaline (MCT; 50 mg/kg, i.p.) to induce PH. Disease progression was monitored via echocardiography. Phosphorescence quenching determined the O2 partial pressure in the interstitial space ( PO2is ) in the spinotrapezius muscle at rest and during contractions under control (SNP-) and NO-donor (sodium nitroprusside, SNP+) conditions. MCT rats displayed right ventricular (RV) hypertrophy (right ventricle/(left ventricle + septum): 0.44 (0.13) vs. 0.28 (0.05)), pulmonary congestion, increased RV systolic pressure (48 (18) vs. 20 (8) mmHg) and arterial hypoxaemia ( PaO2 : 64 (9) vs. 82 (9) mmHg) compared to healthy controls (HC) (P < 0.05). PO2is was significantly lower in MCT rats during the first 30 s of SNP- contractions. SNP superfusion elevated PO2is in both groups; however, MCT rats demonstrated a lower PO2is throughout SNP+ contractions versus HC (P < 0.05). Thus, for small muscle mass exercise in MCT rats, muscle oxygenation is impaired across the rest-to-contractions transition and exogenous NO does not raise the Q̇O2 -to- V̇O2 ratio in contracting muscle to the same levels as HC. These data support muscle Q̇O2 -to- V̇O2 mismatch as a potential contributor to slow V̇O2 kinetics and therefore exercise intolerance in PH and suggest peripheral vascular dysfunction or remodelling as a possible mechanism.
© 2021 The Authors. Experimental Physiology © 2021 The Physiological Society.

Entities:  

Keywords:  microvasculature; monocrotaline; nitric oxide; oxygen transport

Mesh:

Substances:

Year:  2021        PMID: 34469618      PMCID: PMC8488011          DOI: 10.1113/EP089631

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.858


  51 in total

1.  Muscle O2 uptake kinetics in humans: implications for metabolic control.

Authors:  B Grassi; D C Poole; R S Richardson; D R Knight; B K Erickson; P D Wagner
Journal:  J Appl Physiol (1985)       Date:  1996-03

2.  Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension.

Authors:  M M Hoeper; M W Pletz; H Golpon; T Welte
Journal:  Eur Respir J       Date:  2007-02-14       Impact factor: 16.671

3.  Spinotrapezius muscle microcirculatory function: effects of surgical exteriorization.

Authors:  J K Bailey; C A Kindig; B J Behnke; T I Musch; G W Schmid-Schoenbein; D C Poole
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

4.  Increased sympathetic nerve activity in pulmonary artery hypertension.

Authors:  Sonia Velez-Roa; Agnieszka Ciarka; Boutaina Najem; Jean-Luc Vachiery; Robert Naeije; Philippe van de Borne
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690

5.  Peripheral muscle microcirculatory alterations in patients with pulmonary arterial hypertension: a pilot study.

Authors:  Stavros Dimopoulos; Georgios Tzanis; Christos Manetos; Athanasios Tasoulis; Anthi Mpouchla; Eleni Tseliou; Ioannis Vasileiadis; Nikos Diakos; John Terrovitis; Serafim Nanas
Journal:  Respir Care       Date:  2013-05-28       Impact factor: 2.258

Review 6.  Cellular and molecular pathobiology of pulmonary arterial hypertension.

Authors:  Marc Humbert; Nicholas W Morrell; Stephen L Archer; Kurt R Stenmark; Margaret R MacLean; Irene M Lang; Brian W Christman; E Kenneth Weir; Oliver Eickelberg; Norbert F Voelkel; Marlene Rabinovitch
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

7.  Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.

Authors:  A Kitabatake; M Inoue; M Asao; T Masuyama; J Tanouchi; T Morita; M Mishima; M Uematsu; T Shimazu; M Hori; H Abe
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

Review 8.  Control of oxygen uptake during exercise.

Authors:  David C Poole; Thomas J Barstow; Paul McDonough; Andrew M Jones
Journal:  Med Sci Sports Exerc       Date:  2008-03       Impact factor: 5.411

9.  Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension.

Authors:  Vincent Mainguy; François Maltais; Didier Saey; Philippe Gagnon; Simon Martel; Mathieu Simon; Steeve Provencher
Journal:  Thorax       Date:  2009-08-30       Impact factor: 9.139

10.  Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.

Authors:  Birger Wolff; Sven Lodziewski; Tom Bollmann; Christian F Opitz; Ralf Ewert
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

View more
  1 in total

1.  Effects of pulmonary hypertension on microcirculatory hemodynamics in rat skeletal muscle.

Authors:  Kiana M Schulze; Ramona E Weber; Andrew G Horn; Trenton D Colburn; Carl J Ade; David C Poole; Timothy I Musch
Journal:  Microvasc Res       Date:  2022-01-30       Impact factor: 3.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.